It’s taken 10 years, but on November 27, 2024, final provisions of the Drug Supply Chain Security Act (DSCSA) are set to take effect.

From that point on, manufacturers, distributors, pharmacists, and other stakeholders will all use the same electronic process to verify the safety of prescription medications, share data, and report instances of suspect or illegitimate drugs. The new process, called a “track and-trace-system,” is a key feature of the DSCSA, and it replaces what had become a patchwork of state reporting requirements, and a series of disconnected, siloed technology systems.

The following analysis provides a detailed overview of the Drug Supply Chain Security Act, including all pharmacist-related compliance requirements. The discussion will also detail how technology-based solutions, including PrimeRx and InfiniTrax, can help ensure seamless and full compliance.